According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), upon the completion of the merger transaction between GlucoTrack, Inc. and Lokahi, the existing shareholders of Lokahi will receive shares equivalent to 19.99% of GlucoTrack's total outstanding common stock at that time.

This document clarifies the equity distribution structure of the merged company. This equity arrangement is one of the key terms of the merger agreement between both parties, aiming to provide Lokahi shareholders with direct ownership interests in the post-merger entity. The transaction remains subject to customary closing conditions, including obtaining relevant regulatory approvals and final consent from shareholders of both parties. The calculation basis for the equity ratio will be based on the actual number of GlucoTrack’s outstanding shares on the effective date of the merger. This merger aims to integrate the resources of both parties and is expected to expand the company’s market coverage and product portfolio in the relevant medical technology sector. The specific merger timetable and other financial details are expected to be disclosed in subsequent announcements.